Stage IIIC Colorectal Cancer AJCC v7 Recruiting Phase 3 Trials for Panitumumab (DB01269)

IndicationStatusPhase
DBCOND0090390 (Stage IIIC Colorectal Cancer AJCC v7)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT033006095-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus PanitumumabTreatment